Opdivoinformationhcp.com

Visit opdivoinformationhcp.com
  • 6 months ago

    Last scanned

  • 7 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

Opdivoinformationhcp.com

Visit opdivoinformationhcp.com

Overal rating:

B9876A78-C14B-4F49-9F4B-396039336A47@1x

About Website

Updated:

OPDIVO® (nivolumab) | Information for Healthcare Professionals

Learn more about OPDIVO® (nivolumab), a prescription medicine that treats certain types of cancers. Please see Indications and Important Safety Information.

Opdivoinformationhcp.com thumbnail
Opdivoinformationhcp.com thumbnail

Trustworthy

99E6BC28-40D1-4264-B66E-CBC423C983BF@1x

Network Data

This website is hosted with Bristol-Myers Squibb Company, which reserves the following IP addresses for opdivoinformationhcp.com: 165.89.235.20. Moreover, DNS used with this website include ns1.bms.com, ns2.bms.com, ns3.bms.com, ns4.bms.com. Subnet identifier ranges from 165.89.0.0 to 165.89.255.255. Classless Inter-Domain Routing (CIDR) is 165.89.0.0/16. ARIN net type is Direct Allocation.

  • 6 months ago

    Last scanned

  • 7 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

Trustworthy

Network

ADDRESSING DETAILS

Whois

OWNERSHIP

Domain & Keywords

The registrar of opdivoinformationhcp.com is CSC CORPORATE DOMAINS, INC. and the name expires on 2024-10-10. According to open source data, you can reach the owner at dns.admin@BMS.COM but please make sure you have a good reason for unsolicited messages. Their country of residence is United States of America.

  • BMS
  • bristol-myers squibb
  • immunotherapy treatment
  • immuno-oncology
  • nivolumab
  • opdivo
  • opdivo prescribing information
  • opdivo package insert
  • nivolumab package insert
  • nivolumab mechanism of action

Websites similar to opdivoinformationhcp.com